Skip to content

Candel Therapeutics, Inc.

CADL Nasdaq SEC CIK 1841387

Follow Candel Therapeutics Weekly email: filings, results, news

News

4 stories filed under Candel Therapeutics

Markets

Thread · 4 stories

Candel Therapeutics stock hits 52-week high at $13.96

Markets 27 d ago 2 sources

Freedom Broker raises Candel Therapeutics stock price target on trial progress

Markets 38 d ago

Candel Therapeutics at canaccord growth conference: prostate cancer push

Markets 43 d ago

Candel Therapeutics: Getting Closer, And Building Out More Paths

Markets 48 d ago

Profile

Headquarters: NEEDHAM, MA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 4 stories clustered from the RSS aggregator